Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.bj.2021.04.006 http://scihub22266oqcxt.onion/10.1016/j.bj.2021.04.006 34193390!8059258!34193390     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34193390&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Biomed+J 2021 ; 44 (3): 235-244 Nephropedia Template TP {{tp|p=34193390|t=2021. Role of SARS-CoV-2 and ACE2 variations in COVID-19 |pdf=|usr=}}{{34193390}} gab.com Text Role of SARS-CoV-2 and ACE2 variations in COVID-19 JO: Biomed J http://www.kidney.de/pget.php?&tw=1&pmid=34193390 #FOAvip Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is one of the worst medical emergencies that has hit the world in almost a century. The virus has now spread to a large number of countries/territories and has caused over three million deaths. Evidently, the virus has been mutating and adapting during this period. Significant effort has been spent on identifying these variations and their impact on transmission, virulence and pathogenicity of SARS-CoV-2. Binding of the SARS-CoV-2 spike protein to the angiotensin converting enzyme 2 (ACE2) promotes cellular entry. Therefore, human ACE2 variations could also influence susceptibility or resistance to the virus. A deeper understanding of the evolution and genetic variations in SARS-CoV-2 as well as ACE2 could contribute to the development of effective treatment and preventive measures. Here, we review the literature on SARS-CoV-2 and ACE2 variations and their role in COVID-19. Twit Text FOAVip Role of SARS-CoV-2 and ACE2 variations in COVID-19 ????Biomed J http://www.kidney.de/pget.php?&tw=1&pmid=34193390 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34193390 #FOAvip English Wikipedia <ref>{{Cite pmid|34193390}}</ref> Role of SARS-CoV-2 and ACE2 variations in COVID-19 #MMPMID34193390 Antony P; Vijayan R Biomed J 2021[Jun]; 44 (3): 235-244 PMID34193390show ga Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is one of the worst medical emergencies that has hit the world in almost a century. The virus has now spread to a large number of countries/territories and has caused over three million deaths. Evidently, the virus has been mutating and adapting during this period. Significant effort has been spent on identifying these variations and their impact on transmission, virulence and pathogenicity of SARS-CoV-2. Binding of the SARS-CoV-2 spike protein to the angiotensin converting enzyme 2 (ACE2) promotes cellular entry. Therefore, human ACE2 variations could also influence susceptibility or resistance to the virus. A deeper understanding of the evolution and genetic variations in SARS-CoV-2 as well as ACE2 could contribute to the development of effective treatment and preventive measures. Here, we review the literature on SARS-CoV-2 and ACE2 variations and their role in COVID-19. |*COVID-19/genetics[MESH] |Angiotensin-Converting Enzyme 2/*genetics[MESH] |Genetic Predisposition to Disease[MESH] |Humans[MESH] |Protein Binding[MESH] |SARS-CoV-2/*genetics[MESH]Role of SARS-CoV-2 and ACE2 variations in COVID-19 (epmc).pdf DeepDyve Pubget Overpricing